Patten & Patten Inc. TN lowered its stake in shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 14.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,040 shares of the software maker’s stock after selling 3,695 shares during the period. Patten & Patten Inc. TN’s holdings in Allscripts Healthcare Solutions were worth $268,000 as of its most recent filing with the SEC.
Several other large investors also recently made changes to their positions in the stock. Thrivent Financial For Lutherans increased its stake in Allscripts Healthcare Solutions by 255.4% in the first quarter. Thrivent Financial For Lutherans now owns 111,780 shares of the software maker’s stock valued at $1,418,000 after buying an additional 80,330 shares in the last quarter. Neuburgh Advisers LLC increased its stake in Allscripts Healthcare Solutions by 4.1% in the first quarter. Neuburgh Advisers LLC now owns 12,070 shares of the software maker’s stock valued at $153,000 after buying an additional 476 shares in the last quarter. Canada Pension Plan Investment Board increased its stake in Allscripts Healthcare Solutions by 12.0% in the first quarter. Canada Pension Plan Investment Board now owns 82,200 shares of the software maker’s stock valued at $1,042,000 after buying an additional 8,800 shares in the last quarter. Credit Agricole S A acquired a new stake in Allscripts Healthcare Solutions during the first quarter valued at approximately $300,000. Finally, Virtu Financial LLC acquired a new stake in Allscripts Healthcare Solutions during the second quarter valued at approximately $134,000.
Allscripts Healthcare Solutions, Inc. (MDRX) traded up 1.60% on Monday, hitting $13.33. 1,096,245 shares of the company were exchanged. The company’s market capitalization is $2.42 billion. The stock has a 50 day moving average of $12.46 and a 200 day moving average of $12.12. Allscripts Healthcare Solutions, Inc. has a 52 week low of $9.80 and a 52 week high of $15.17.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings results on Thursday, August 3rd. The software maker reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.15 by $0.04. Allscripts Healthcare Solutions had a positive return on equity of 5.97% and a negative net margin of 11.54%. The business had revenue of $426.10 million during the quarter, compared to analysts’ expectations of $424.94 million. During the same period in the previous year, the business earned $0.14 EPS. The business’s revenue was up 10.2% compared to the same quarter last year. Analysts predict that Allscripts Healthcare Solutions, Inc. will post $0.62 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This piece was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://stocknewstimes.com/2017/08/07/allscripts-healthcare-solutions-inc-mdrx-shares-sold-by-patten-patten-inc-tn-updated-updated.html.
Several equities research analysts recently commented on MDRX shares. Zacks Investment Research upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Wednesday, April 19th. Maxim Group reiterated a “buy” rating and set a $16.00 target price on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. Piper Jaffray Companies reiterated a “hold” rating and set a $14.00 target price on shares of Allscripts Healthcare Solutions in a research report on Friday, July 21st. BidaskClub upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Saturday, June 24th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and set a $13.00 target price on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and ten have issued a buy rating to the company. Allscripts Healthcare Solutions presently has a consensus rating of “Hold” and an average price target of $14.66.
In related news, President Richard J. Poulton sold 25,000 shares of the firm’s stock in a transaction on Tuesday, May 16th. The stock was sold at an average price of $12.06, for a total value of $301,500.00. Following the completion of the sale, the president now owns 412,488 shares of the company’s stock, valued at $4,974,605.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.75% of the company’s stock.
Allscripts Healthcare Solutions Company Profile
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
